Literature DB >> 21802719

With maturity comes confidence: EBCTCG tamoxifen update.

Stephen K Chia1, Antonio C Wolff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21802719     DOI： 10.1016/S0140-6736(11)61128-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  Breast magnetic resonance imaging: are those who need it getting it?

Authors:  S Tan; J David; L Lalonde; M El Khoury; M Labelle; R Younan; E Patocskai; J Richard; I Trop
Journal:  Curr Oncol       Date:  2017-06-27       Impact factor: 3.677

2.  Time resolved gene expression analysis during tamoxifen adaption of MCF-7 cells identifies long non-coding RNAs with prognostic impact.

Authors:  Martin Porsch; Esra Özdemir; Martin Wisniewski; Sebastian Graf; Fabian Bull; Katrin Hoffmann; Atanas Ignatov; Johannes Haybaeck; Ivo Grosse; Thomas Kalinski; Norbert Nass
Journal:  RNA Biol       Date:  2019-03-05       Impact factor: 4.652

3.  Quantitative analysis of estrogen receptor expression shows SP1 antibody is more sensitive than 1D5.

Authors:  Allison W Welsh; Malini Harigopal; Hallie Wimberly; Manju Prasad; David L Rimm
Journal:  Appl Immunohistochem Mol Morphol       Date:  2013-03

4.  Accumulation of the advanced glycation end product carboxymethyl lysine in breast cancer is positively associated with estrogen receptor expression and unfavorable prognosis in estrogen receptor-negative cases.

Authors:  Norbert Nass; Atanas Ignatov; Ludwig Andreas; Christine Weißenborn; Thomas Kalinski; Saadettin Sel
Journal:  Histochem Cell Biol       Date:  2016-12-23       Impact factor: 4.304

5.  Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature.

Authors:  M Opdam; V van der Noort; M Kleijn; A Glas; I Mandjes; S Kleiterp; F S Hilbers; D T Kruger; A D Bins; P C de Jong; P P J B M Schiphorst; T van Dalen; B Flameling; R C Rietbroek; A Beeker; S M van den Heiligenberg; S D Bakker; A N M Wymenga; I M Oving; R M Bijlsma; P J van Diest; J B Vermorken; H van Tinteren; S C Linn
Journal:  Breast Cancer Res Treat       Date:  2022-05-19       Impact factor: 4.624

6.  A gene signature for late distant metastasis in breast cancer identifies a potential mechanism of late recurrences.

Authors:  Lorenza Mittempergher; Mahasti Saghatchian; Denise M Wolf; Stefan Michiels; Sander Canisius; Philippe Dessen; Suzette Delaloge; Vladimir Lazar; Stephen C Benz; Thomas Tursz; René Bernards; Laura J van't Veer
Journal:  Mol Oncol       Date:  2013-07-17       Impact factor: 6.603

7.  Skeletal and Uterotrophic Effects of Endoxifen in Female Rats.

Authors:  Anne Gingery; Urszula T Iwaniec; Malayannan Subramaniam; Russell T Turner; Kevin S Pitel; Renee M McGovern; Joel M Reid; Ronald J Marler; James N Ingle; Matthew P Goetz; John R Hawse
Journal:  Endocrinology       Date:  2017-10-01       Impact factor: 4.736

Review 8.  Clinical Applications of Extracellular Vesicles in the Diagnosis and Treatment of Traumatic Brain Injury.

Authors:  Kryshawna Beard; David F Meaney; David Issadore
Journal:  J Neurotrauma       Date:  2020-06-02       Impact factor: 4.869

9.  Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: an exploratory analysis of TEXT and SOFT.

Authors:  M M Regan; B A Walley; P A Francis; G F Fleming; I Láng; H L Gómez; M Colleoni; C Tondini; G Pinotti; M Salim; S Spazzapan; V Parmar; T Ruhstaller; E A Abdi; R D Gelber; A S Coates; A Goldhirsch; O Pagani
Journal:  Ann Oncol       Date:  2017-09-01       Impact factor: 32.976

10.  Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine Resistance.

Authors:  Rebecca Bellerby; Chris Smith; Sue Kyme; Julia Gee; Ursula Günthert; Andy Green; Emad Rakha; Peter Barrett-Lee; Stephen Hiscox
Journal:  Front Oncol       Date:  2016-06-20       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.